Pharma Journalist -

Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and ADC-based therapies, announced that it has received another milestone payment from…
Read More...

Pfizer Inc. and BioNTech SE announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11 years of age using…
Read More...

Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the U.S. Food and Drug Administration (FDA) has approved BYOOVIZ (ranibizumab-nuna), a biosimilar referencing LUCENTIS…
Read More...

Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, announces the signing of an exclusive US license agreement with FAES Farma S.A. to…
Read More...

Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended use in…
Read More...

SMi Reports: Leading pharmaceutical microbiologists and industry experts to meet at SMi’s 10th Anniversary Pharmaceutical Microbiology UK Conference taking place in London on 17-18…
Read More...

PerkinElmer, Inc. a global leader committed to innovating for a healthier world, announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science…
Read More...

Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum Institute of India Pvt. Ltd. today announced…
Read More...

Sanofi announced the completion of its acquisition of Translate Bio, further accelerating the company’s efforts to develop transformative vaccines and therapies using mRNA technology.…
Read More...

Read More...